Clinical Trial Update: FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a first-in-man study (Brazil part) of a sirolimus-coated BX VELOCITY drug-eluting stent for coronary artery disease, spann…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-Coated BX VELOCITY Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED